Taiyo Holdings

4626.TTSE PRIMEChemicals

Financials · Consolidated

Fiscal year ended	2026-03	2025-03	2024-03	2023-03	2022-03	2021-03
Revenue	¥137.9bn	¥119.0bn	¥104.8bn	¥97.3bn	¥98.0bn	¥81.0bn
Operating income	¥32.5bn	¥22.1bn	¥18.2bn	¥16.0bn	¥18.0bn	¥13.9bn
Ordinary income	¥32.2bn	¥21.6bn	¥17.3bn	¥15.5bn	¥18.1bn	¥13.8bn
Net income (owners)	¥24.0bn	¥10.8bn	¥8.7bn	¥11.4bn	¥11.8bn	¥9.5bn
Total assets	¥201.9bn	¥192.0bn	¥212.8bn	¥187.3bn	¥189.3bn	¥179.0bn
Net assets / equity	¥115.8bn	¥103.0bn	¥100.4bn	¥92.7bn	¥85.5bn	¥76.5bn
Operating cash flow	¥30.7bn	¥23.7bn	¥21.2bn	¥22.7bn	¥18.3bn	¥16.3bn
EPS (basic)	¥215.92	¥96.59^r	¥77.44^r	¥101.86^r	¥104.56^r	¥167.49

From EDINET filings. Select any figure to open the report it came from. ^r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 4

All Annual 5 Half-year 2 Quarterly 6All years 2026 2025 2024 2023 2022

Period	Form	Filed	Figures
2023-04-01 → 2023-12-31	Quarterly Q3	2024-02-02	45 figures · EDINET
2023-04-01 → 2023-09-30	Quarterly Q2	2023-11-06	69 figures · EDINET
2023-04-01 → 2023-06-30	Quarterly Q1	2023-08-01	43 figures · EDINET
2022-04-01 → 2023-03-31	Annual	2023-06-19	196 figures · EDINET

22 more reports are still being processed.

Segments · FY ended 2026-03

Segment	External sales	Profit	Assets
Electronics Materials	¥95.3bn	¥29.2bn	¥97.8bn
Medical And Pharmaceutical	¥36.5bn	¥5.1bn	¥61.9bn
Other segments	¥6.1bn	−¥95m	¥10.4bn
Total	¥131.8bn	¥34.2bn	¥159.7bn
Total	¥137.9bn	¥34.1bn	¥170.1bn

Segment names from EDINET member IDs; not mapped to a common taxonomy.